section name header

Basics

Description!!navigator!!
Epidemiology!!navigator!!

Incidence

  • Worldwide, rheumatic heart disease is the most common cause of AR.
  • In the US, congenital and degenerative valvular and aortic disease is most common.
  • Congenital bicuspid aortic valves occur in 1–2% of the US population and may contribute to AR.

Prevalence

  • 13% in men, 8.5% in women in a Framingham study (2)
  • In the US population, severe AR is <1% (3).
  • Chronic AR is more prevalent than acute AR.

Morbidity

  • Acute AR has a higher rate of morbidity and mortality due to the underlying pathophysiology. This can result in diastolic and systolic dysfunction and eventually decompensation (CHF).
  • Chronic AR mortality is related to the eventual decompensation of the LV; it is more common in severe AR. Decreased ejection fraction and LV function have a poor prognosis for recovery, even after repair.
  • Surgical management becomes the common end point to both types of AR.

Mortality

  • Acute AR has a high mortality due to sudden uncompensated cardiovascular changes usually requiring immediate surgical management.
  • Chronic AR mortality relates to eventual decompensation of the LV and may occur at any age usually with severe AR. Decreased ejection fraction and LV function has a poor prognosis for recovery even after repair.
  • Yearly mortality risk relates to NYHA classification for chronic severe AR:
    • Asymptomatic: 2.8%
    • NYHA Class I: 3.0%
    • NYHA Class II: 6.3%
    • NYHA Class III–IV: 24.6% (4)
Etiology/Risk Factors!!navigator!!
Physiology/Pathophysiology!!navigator!!
Anesthetic GOALS/GUIDING Principles!!navigator!!

Outline

Diagnosis

Symptoms!!navigator!!

History

  • Family history of cardiac valvular disease, collagen or connective tissue disease, or congenital malformations
  • History of rheumatic disease or risk factors for endocarditis
  • Commonly diagnosed after symptomatic exercise or during workup for diastolic or systolic CHF
  • May be discovered early after detailed physical exam and auscultation of heart murmur
  • Usually classified by echocardiographic measurement of color Doppler flow across the valve

Signs/Physical Exam

  • Syncope
  • Cyanosis
  • Decrescendo diastolic murmur
  • Watson's hammer pulse (bounding pulse)
  • Corrigan's carotid pulse
  • Wide pulse pressure
  • Signs of CHF
Treatment History!!navigator!!
Medications!!navigator!!
Diagnostic Tests & Interpretation!!navigator!!

Labs/Studies

  • Basic metabolic profile: Monitoring electrolytes and kidney function
  • CBC: Monitoring for preoperative infection and hematocrit and platelet counts adequate for surgery
  • CXR: Cardiopulmonary status
  • CT scan for evaluation of aorta
  • Echocardiogram: Diagnosis and classification of disease severity and ventricular function
  • Basic coagulation studies: Adequate levels for surgery and evaluation of liver function
CONCOMITANT ORGAN DYSFUNCTION!!navigator!!
Circumstances to delay/Conditions!!navigator!!
Classifications!!navigator!!

Severe AR criteria:


Outline

Treatment

PREOPERATIVE PREPARATION!!navigator!!

Premedications

Midazolam to prevent anxiety and increased sympathetic tone, as appropriate

INTRAOPERATIVE CARE!!navigator!!

Choice of Anesthesia

  • Depends on the procedure; sedation, general (endotracheal tube or laryngeal mask airway) and regional anesthesia may be utilized.
  • Neuraxial techniques can result in a sympathectomy and facilitate forward flow (reduce regurgitation), but may reduce coronary perfusion pressure.

Monitors

  • Standard ASA monitors
  • Invasive monitors may be chosen based upon the severity of AR and the surgical procedure.

Induction/Airway Management

  • Smooth, controlled induction to maintain vital signs within normal limits
  • Anticholinergic medications may be administered to maintain a NSR and slightly increase the heart rate.

Maintenance

  • Volatile and/or intravenous anesthetics may be utilized. Reductions in SVR are desirable to facilitate forward flow; however, adequate cerebral and coronary perfusion should be ensured. Total intravenous techniques may be associated with bradycardia, particularly if utilizing high doses of remifentanil.
  • Fluid balance includes maintaining normal preload and hematocrit >24–30 g/dL to optimize forward flow and myocardial oxygen balance. Excessive preload may add to regurgitant volume and cause LV failure.

Extubation/Emergence

No additional concerns


Outline

Follow-Up

Bed Acuity!!navigator!!

Depends on surgical procedure and severity of underlying disease

Medications/Lab Studies/Consults!!navigator!!

Standard postoperative fluid and electrolyte management and related laboratory studies

Complications!!navigator!!

Perioperative arrhythmia


Outline

References

  1. Odili AN , Amusa GA. Aortic aneurysm with valvular insufficiency: Is it due to Marfan syndrome or hypertension? A case report and review of literature. J Vasc Nurs. 2011;29(1):1622.
  2. Singh JP , Evans JC , Levy D , et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation. Am J Cardiol. 1999;83:897902.
  3. Maurer G. Aortic regurgitation. Heart. 2006;92(7):9941000.
  4. Dujardin KS , Enriquez-Sarano M , Schaff HV , et al. Mortality and morbidity of aortic regurgitation in clinical practice: A long-term follow-up study. Circulation. 1999;99(14):18511857.

Additional Reading

Codes

ICD9!!navigator!!
ICD10!!navigator!!

Outline

Clinical Pearls

Author(s)

Brian L. Marasigan , MD